Skip to main content
GutCited

Fructooligosaccharides (FOS) pour Irritable Bowel Syndrome (IBS)

D

Mixed results. Low doses may help (5 g) but higher doses can worsen bloating due to rapid fermentation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dfructooligosaccharides\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

D

En conclusion

Mixed results. Low doses may help (5 g) but higher doses can worsen bloating due to rapid fermentation.

Key Study Findings

Other
FODMAP Profile of Wholegrain Pasta.
Dose: None vs: None Outcome: FODMAP compound content in pasta (analytical) Effet: None None

Population: Commercially available pasta products (analytical study)

Randomized Controlled Trial n=9 12 weeks
Modification of the Low FODMAP Diet Is Feasible in the Treatment of Irritable Bowel Syndrome: …
Dose: None vs: Baseline; crossover between 3 diets Outcome: Birmingham IBS questionnaire symptom score Effet: 75% relief on low FOS+GOS; 62.5% on FODMAP p<0.05

Population: IBS patients (Rome IV criteria)

Other
Biotechnological Tools for the Production of Low-FODMAP Wholegrain Wheat and Rye Cookies and Crackers.
Dose: None vs: Standard wholegrain flour products Outcome: FODMAP content reduction in cookies and crackers Effet: Up to 99.5% FODMAP reduction (wheat malt) None

Population: Laboratory food science study (no human subjects)

Randomized Controlled Trial 12 weeks Double-blind
Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides …
Dose: None vs: Placebo Outcome: Quality of life Effet: None p = 0.023

Population: IBS patients

In Vitro
Microbial inulinase promotes fructan hydrolysis under simulated gastric conditions.
Dose: None vs: None Outcome: None Effet: None None

Population: None

Controlled Clinical Trial n=54 3.0 weeks
[Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with …
Dose: 350 mg vs: None Outcome: IBS symptom improvement Effet: None None

Population: Irritable bowel syndrome with diarrhea and antibiotic-associated diarr

Key Statistics

2

Études

150

Participants

Mixed

D

Note

Referenced Papers

Foods (Basel, Switzerland) 2025 3 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
2-10 g/day
prebioticeffect:
5-8 g/day for bifidogenic effect
constipationsupport:
5-10 g/day

Limite supérieure : Well-tolerated up to 20 g/day; start low to avoid excess gas

Posologies étudiées dans la recherche

Posologie Durée Effet N
None -- Neutral --
None 12 weeks Positive 9
None -- Positive --
None 12 weeks Positive --
None -- Mixed --
350 mg 3.0 weeks Positive 54
None -- Mixed --
None -- Negative --

Moment optimal de prise : With meals; divide doses throughout the day

Safety & Side Effects

Effets indésirables signalés

  • Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day)
  • Abdominal cramping at higher doses
  • May worsen IBS symptoms in FODMAP-sensitive individuals
  • Loose stools at excessive doses

Interactions connues

  • Other FODMAPs (cumulative fermentation effect in sensitive individuals)
  • Blood sugar-lowering medications (FOS may modestly affect glycemic response)
  • Calcium supplements (FOS may enhance calcium absorption)

Apport maximal tolérable : Well-tolerated up to 20 g/day; start low to avoid excess gas

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Fructooligosaccharides (FOS) help with Irritable Bowel Syndrome (IBS)?
Based on 2 studies with 150 participants, there is preliminary evidence that needs more research that Fructooligosaccharides (FOS) may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is D (Very Early Research).
How much Fructooligosaccharides (FOS) should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Fructooligosaccharides (FOS)?
Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Fructooligosaccharides (FOS) and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 150 total participants. The overall direction of effect is mixed.

Related Evidence

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.